申请人:Chakravarty K. Prasun
公开号:US20080015190A1
公开(公告)日:2008-01-17
The present invention relates to hydroxamic acid derivatives that are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases. Further, the compounds of the present invention have antiprotozoal properties.
本发明涉及羟羧酰胺酸衍生物,这些衍生物是组蛋白去乙酰化酶(HDAC)的抑制剂。本发明的化合物可用于治疗细胞增殖性疾病,包括癌症。此外,本发明的化合物可用于治疗神经退行性疾病、精神分裂症和中风等其他疾病。此外,本发明的化合物具有抗原虫特性。